Consolidated Statement of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities:
Net Loss	$ (3,401,522)	$ (2,428,483)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	493,123	717,384
Stock compensation expense	227,129	122,107
Accretion for debt discounts and issuance costs	320,979	79,461
Shares issued in exchange for services	31,144
Changes in operating assets and liabilities:
Accounts receivable	(1,114)	1,185
Prepaid expenses and other assets	(41,636)	6,460
Accounts payable, net of conversion to shares	(167,476)	145,456
Deposits		(150,000)
Accrued interest and other liabilities	146,230	39,876
Deferred revenue	287,583	28,267
Deferred rent	(3,392)	(10,138)
Net Cash Used In Operating Activities	(2,108,952)	(1,448,425)
Cash Flows From Investing Activities:
Purchase of fixed assets	(31,824)	(16,342)
Payment for patent application	(10,000)
Payment of platform development costs	(519,734)	(548,030)
Net Cash Used In Investing Activities	(561,558)	(564,372)
Cash Flows From Financing Activities
Proceeds from notes payable related parties	122,456	505,526
Repayments on notes payable and interest on convertible debt to related parties	(245,131)	(177,500)
Repayment of convertible note	(20,106)
Proceeds from exercise of common stock options	38,531
Proceeds from debentures, net of issuance costs		523,081
Sale of common stock, net of issuance costs	3,573,100	1,052,279
Net Cash Provided By Financing Activities	3,468,850	1,903,386
Net Increase (Decrease) in Cash and Cash Equivalents	798,340	(109,411)
Cash, Beginning of Period	13,724	123,135
Cash, End of Period	812,064	13,724
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for interest	27,696
Non-cash Investing and Financing Transactions:
Conversion of convertible note to common stock shares	32,006
Issuance of stock in acquisition of subsidiary		$ 325